They showed a better trend for survival with chemotherapy rechallenge if time to rechallenge was more than 6 months, but this also did not reach statistical significance. Kostek et al.
← all excerpts
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
1
—
—